{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:33:33Z","timestamp":1792089213925,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Research Funding for University of Catania"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.colsurfb.2019.110705","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T12:10:26Z","timestamp":1575375026000},"page":"110705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["Dual-drugs delivery in solid lipid nanoparticles for the treatment of Candida albicans mycosis"],"prefix":"10.1016","volume":"186","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3592-752X","authenticated-orcid":false,"given":"C.","family":"Carbone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0405-5095","authenticated-orcid":false,"given":"V.","family":"Fuochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2603-1377","authenticated-orcid":false,"given":"A.","family":"Zieli\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2299-7780","authenticated-orcid":false,"given":"T.","family":"Musumeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9737-6017","authenticated-orcid":false,"given":"E.B.","family":"Souto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3392-1258","authenticated-orcid":false,"given":"A.","family":"Bonaccorso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7694-3641","authenticated-orcid":false,"given":"C.","family":"Puglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Petronio Petronio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"Furneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 6","key":"10.1016\/j.colsurfb.2019.110705_bib0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/1469-0691.12622","article-title":"Antifungal stewardship in invasive Candida infections","volume":"20","author":"Ruhnke","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0010","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.2147\/IJN.S93105","article-title":"Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?","volume":"11","author":"Voltan","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0015","article-title":"Antifungal activity of extracts produced by Lactobacillus fermentum strains and analysis of Candida albicans yeast\/mold (Y\/M) switching","volume":"52","author":"Fuochi","year":"2018","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/jof4030097","article-title":"Treatment of invasive candidiasis: a narrative review","volume":"4","author":"Ben-Ami","year":"2018","journal-title":"J. Fungi"},{"key":"10.1016\/j.colsurfb.2019.110705_bib0025","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/jam.12554","article-title":"Clotrimazole as a pharmaceutical: past, present and future","volume":"117","author":"Crowley","year":"2014","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0030","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1128\/am.22.5.891-898.1971","article-title":"Chemotherapeutic evaluation of clotrimazole (Bay b 5097, 1 (o-chloro- - -diphenylbenzyl) imidazole)","volume":"22","author":"Waitz","year":"1971","journal-title":"Appl. Microbiol."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0035","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.colsurfb.2015.10.003","article-title":"Solid lipid nanoparticles of clotrimazole silver complex: An efficient nano antibacterial against Staphylococcus aureus and MRSA","volume":"136","author":"Kalhapure","year":"2015","journal-title":"Colloids Surf. B, Biointerfaces"},{"key":"10.1016\/j.colsurfb.2019.110705_bib0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.archoralbio.2016.10.011","article-title":"Clotrimazole and econazole inhibit Streptococcus mutans biofilm and virulence in vitro","volume":"73","author":"Qiu","year":"2017","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0045","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/bj2660475","article-title":"Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14 alpha-sterol demethylase purified from Candida albicans","volume":"266","author":"Hitchcock","year":"1990","journal-title":"Biochem. J."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0050","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.4103\/0366-6999.181964","article-title":"Species distribution and in vitro antifungal susceptibility of vulvovaginal Candida Isolates in China","volume":"129","author":"Wang","year":"2016","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0055","series-title":"Nanosized Devices as Antibiotics and Antifungals Delivery: Past,news, and Outlook, Nanostructures for Drug Delivery","first-page":"697","author":"Furneri","year":"2017"},{"key":"10.1016\/j.colsurfb.2019.110705_bib0060","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11050231","article-title":"Clotrimazole-loaded mediterranean essential oils NLC: a synergic treatment of Candida skin infections","volume":"11","author":"Carbone","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2019.110705_bib0065","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2019.03.010","article-title":"Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)\/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe\/PS1dE9 Alzheimer\u2019s disease mice model","volume":"301","author":"Cano","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2019.110705_bib0070","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1007\/s11095-015-1677-3","article-title":"Dual drug delivery using lactic acid conjugated SLN for effective management of Neurocysticercosis","volume":"32","author":"Devi","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0075","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.msec.2016.05.119","article-title":"Solid lipid nanoparticles as attractive drug vehicles: composition, properties and therapeutic strategies","volume":"68","author":"Geszke-Moritz","year":"2016","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0080","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3109\/13880209.2012.761245","article-title":"Dual ligands modified double targeted nano-system for liver targeted gene delivery","volume":"51","author":"Jing","year":"2013","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0085","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3892\/ol.2016.5421","article-title":"Solid lipid nanoparticles with TPGS and Brij 78: a co-delivery vehicle of curcumin and piperine for reversing P-glycoprotein-mediated multidrug resistance in vitro","volume":"13","author":"Tang","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0090","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.3109\/10717544.2015.1058434","article-title":"Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery","volume":"23","author":"Wu","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0095","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.colsurfb.2016.02.002","article-title":"Innovative hybrid vs polymeric nanocapsules: the influence of the cationic lipid coating on the \"4S\"","volume":"141","author":"Carbone","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2019.110705_bib0100","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/IJN.S100625","article-title":"Miconazole-loaded solid lipid nanoparticles: formulation and evaluation of a novel formula with high bioavailability and antifungal activity","volume":"11","author":"Aljaeid","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1208\/s12249-009-9199-0","article-title":"Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery","volume":"10","author":"Bhalekar","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.colsurfb.2019.110705_bib0110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/jac\/44.3.397","article-title":"In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole","volume":"44","author":"Carrillo-Munoz","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0115","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3109\/10717544.2014.932862","article-title":"Preparation, characterization and in vitro activities evaluation of solid lipid nanoparticles based on PEG-40 stearate for antifungal drugs vaginal delivery","volume":"23","author":"Cassano","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejps.2012.05.010","article-title":"Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?","volume":"47","author":"Das","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0125","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.msec.2012.09.007","article-title":"Clotrimazole nanoparticle gel for mucosal administration","volume":"33","author":"Esposito","year":"2013","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.colsurfb.2018.04.031","article-title":"Repurposing itraconazole to the benefit of skin cancer treatment: a combined azole-DDAB nanoencapsulation strategy","volume":"167","author":"Carbone","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2019.110705_bib0135","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/02652040500435295","article-title":"Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization","volume":"23","author":"Souto","year":"2006","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0140","first-page":"505","article-title":"Rheological and in vitro release behaviour of clotrimazole-containing aqueous SLN dispersions and commercial creams","volume":"62","author":"Souto","year":"2007","journal-title":"Die Pharmazie"},{"key":"10.1016\/j.colsurfb.2019.110705_bib0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejpb.2016.10.022","article-title":"Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: pharmacokinetic and pharmacodynamic evaluation","volume":"110","author":"Dudhipala","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejpb.2016.10.013","article-title":"Lipid nanoparticles (SLN, NLC): overcoming the anatomical and physiological barriers of the eye - Part II - ocular drug-loaded lipid nanoparticles","volume":"110","author":"Sanchez-Lopez","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijpharm.2016.06.131","article-title":"Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid ascompared with conventional solid lipid nanoparticles","volume":"511","author":"Zhang","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0160","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jconrel.2014.09.005","article-title":"Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression","volume":"194","author":"Shi","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2019.110705_bib0165","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ejpb.2011.11.002","article-title":"Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA","volume":"80","author":"Yu","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0170","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.colsurfb.2014.02.045","article-title":"Ion pairing with linoleic acid simultaneously enhances encapsulation efficiency and antibacterial activity of vancomycin in solid lipid nanoparticles","volume":"117","author":"Kalhapure","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2019.110705_bib0175","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jchromb.2015.07.029","article-title":"Quantification of lipoic acid from skin samples by HPLC using ultraviolet, electrochemical and evaporative light scattering detectors","volume":"1019","author":"Campos","year":"2016","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0180","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S1734-1140(11)70600-4","article-title":"Lipoic acid - biological activity and therapeutic potential","volume":"63","author":"Goraca","year":"2011","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0185","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s100960000334","article-title":"In vitro activity of a new liposomal nystatin formulation against opportunistic fungal pathogens","volume":"19","author":"Quindos","year":"2000","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0190","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.colsurfb.2011.06.025","article-title":"Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye","volume":"88","author":"Araujo","year":"2011","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2019.110705_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2014.05.024","article-title":"The critical role of didodecyldimethylammonium bromide on physico-chemical, technological and biological properties of NLC","volume":"121","author":"Carbone","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2019.110705_bib0200","series-title":"M60 Performance Standards for Antifungal Susceptibility Testing of Yeasts","author":"CLSI","year":"2017"},{"key":"10.1016\/j.colsurfb.2019.110705_bib0205","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24122333","article-title":"Development of a method for the quantification of clotrimazole and itraconazole and study of their stability in a new microemulsion for the treatment of Sporotrichosis","volume":"24","author":"Garcia Ferreira","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2019.110705_bib0210","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijpharm.2015.03.001","article-title":"Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization","volume":"485","author":"Laserra","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0215","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijbiomac.2015.12.077","article-title":"Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: optimization, in vitro release, ocular tolerance, and antibacterial activity","volume":"85","author":"Baig","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0220","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejpb.2016.10.006","article-title":"Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: pharmacokinetic studies on rabbits","volume":"109","author":"Chetoni","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0225","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3109\/1061186X.2014.939983","article-title":"Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma: vitro and vivo study","volume":"22","author":"Wang","year":"2014","journal-title":"J. Drug Target."},{"key":"10.1016\/j.colsurfb.2019.110705_bib0230","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ijpharm.2013.06.015","article-title":"Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies","volume":"454","author":"Ravani","year":"2013","journal-title":"Int. J. Pharm."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776519308495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776519308495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:42:38Z","timestamp":1760524958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776519308495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":46,"alternative-id":["S0927776519308495"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2019.110705","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-drugs delivery in solid lipid nanoparticles for the treatment of Candida albicans mycosis","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2019.110705","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110705"}}